HDI’s Chinese distributor, ShenZhen Filiale Shen Yong Medical-Pharmacal Co., Ltd. of Shenzhen will also be exhibiting the CVProfilor^® System at this meeting.
Dr. Cohn has also been invited to speak at two additional meetings during his visit to China. The Asian-Pacific Cardiothoracic-Renal Association (APCRA) is holding its 2nd Annual Meeting in Beijing and has requested that Dr. Cohn speak on heart failure, a subject about which he is considered to be an international expert. The Beijing Cardiovascular Institute and Hospital of Hebei Province and TianJin invited Dr. Cohn to provide a two-hour lecture to approximately 75 practicing physicians. This lecture will focus on the clinical applications of the CVProfilor^® System.

“These meetings present a tremendous opportunity to help Chinese physicians further their efforts in preventing the complications associated with cardiovascular disease,” said Dr. Cohn. “There are 50-60 million patients with hypertension in China and cardiovascular disease, which represents 30% of all deaths, claims the lives of approximately 2.5 million people annually,” added Dr. Cohn.

Hypertension Diagnostics, Inc. designs, develops, manufactures and markets proprietary cardiovascular profiling systems for medical applications and clinical research. These systems are marketed to physicians, other health care professionals and researchers by a direct sales force and via distributors throughout the world. In addition to providing blood pressure values, the systems non-invasively detect subtle changes in the compliance or elasticity of both large and small arteries which is a unique feature of HDI’s technology.

Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2001 Annual Report on Form 10-KSB under the caption “Risk Factors,” as well as others not now anticipated.

CVProfilor is a registered trademark of Hypertension Diagnostics, Inc.
  
Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Contact: Greg H. Guettler, President